Table of Contents
ISRN Pathology
Volume 2012, Article ID 283670, 7 pages
http://dx.doi.org/10.5402/2012/283670
Clinical Study

Analysis of the Distribution and Temporal Trends of Grade and Stage in Urothelial Bladder Cancer in Northern New England from 1994 to 2004

1Department of Pathology, Dartmouth Medical School, Hanover, New Hampshire, NH 03756, USA
2Division of Cancer Epidemiology and Genetics, Science Applications International Corporation-Frederick, Inc., National Cancer Institute-Frederick, Frederick, MD 21702, USA
3Clinical Monitoring Research Program, Occupational and Environmental Epidemiology Branch, SAIC-Frederick, Inc., National Cancer Institute, 6120 Executive Plaza South, RM 8007, Rockville, MD 20852, USA
4Occupational and Environmental Epidemiology Branch, Epidemiology and Biostatistics Program, National Cancer Institute, NIH, DHHS, Bethesda, MD 20852, USA
5Vermont Cancer Registry, Burlington, Vermont, VT 05402, USA
6Department of Pathology and Laboratory Medicine, Maine Medical Center Portland, ME 04102, USA
7Department of Pathology, University of Vermont College of Medicine, Burlington, VT 05405, USA
8Maine Cancer Registry, Augusta, ME 04333, USA
9Department of Pathology and Laboratory Medicine, Brown University, Providence, RI 02912, USA
10Section of Biostatistics and Epidemiology, Dartmouth Medical School, Hanover, NH 03756, USA

Received 11 January 2012; Accepted 31 January 2012

Academic Editors: A. Handra-Luca, A.-J. Kruse, and A.-G. Selim

Copyright © 2012 Alan R. Schned et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. T. Silverman, P. Hartge, A. S. Morrison, and S. S. Devesa, “Epidemiology of bladder cancer,” Hematology/Oncology Clinics of North America, vol. 6, no. 1, pp. 1–30, 1992. View at Google Scholar · View at Scopus
  2. D. Baris, M. R. Karagas, C. Verrill et al., “A case-control study of smoking and bladder cancer risk: emergent patterns over time,” Journal of the National Cancer Institute, vol. 101, no. 22, pp. 1553–1561, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. M. S. Soloway, D. S. Bruck, and S. S. Kim, “Expectant management of small, recurrent, noninvasive papillary bladder tumors,” Journal of Urology, vol. 170, no. 2 I, pp. 438–441, 2003. View at Google Scholar · View at Scopus
  4. J. P. Stein, G. Lieskovsky, R. Cote et al., “Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients,” Journal of Clinical Oncology, vol. 19, no. 3, pp. 666–675, 2001. View at Google Scholar · View at Scopus
  5. F. M. Jhaveri, E. A. Klein, P. A. Kupelian, C. Zippe, and H. S. Levin, “Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration,” Journal of Clinical Oncology, vol. 17, no. 10, pp. 3167–3172, 1999. View at Google Scholar · View at Scopus
  6. C. J. Kane, K. Mallin, J. Ritchey, M. R. Cooperberg, and P. R. Carroll, “Renal cell cancer stage migration: analysis of the National Cancer Data Base,” Cancer, vol. 113, no. 1, pp. 78–83, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. A. M. Nieder, J. A. MacKinnon, Y. Huang, L. E. Fleming, L. G. Koniaris, and D. J. Lee, “Florida bladder cancer trends 1981 to 2004: minimal progress in decreasing advanced disease,” Journal of Urology, vol. 179, no. 2, pp. 491–495, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. K. A. David, K. Mallin, M. I. Milowsky, J. Ritchey, P. R. Carroll, and D. M. Nanus, “Surveillance of urothelial carcinoma: stage and grade migration, 1993–2005 and survival trends, 1993–2000,” Cancer, vol. 115, no. 7, pp. 1435–1447, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. M. R. Karagas, T. D. Tosteson, J. S. Morris et al., “Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire,” Cancer Causes and Control, vol. 15, no. 5, pp. 465–472, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. A. R. Schned, A. S. Andrew, C. J. Marsit, K. T. Kelsey, M. S. Zens, and M. R. Karagas, “Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States,” Scandinavian Journal of Urology and Nephrology, vol. 42, no. 3, pp. 237–242, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. I. Epstein, M. B. Amin, V. R. Reuter et al., “The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder,” American Journal of Surgical Pathology, vol. 22, no. 12, pp. 1435–1448, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Miyamoto, J. S. Miller, D. A. Fajardo, T. K. Lee, G. J. Netto, and J. I. Epstein, “Non-invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system,” Pathology International, vol. 60, no. 1, pp. 1–8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Cheng, R. Montironi, D. D. Davidson, and A. Lopez-Beltran, “Staging and reporting of urothelial carcinoma of the urinary bladder,” Modern Pathology, vol. 22, no. 2, pp. S70–S95, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. R. B. Hayes, G. H. Friedell, S. H. Zahm, and P. Cole, “Are the known bladder cancer risk-factors associated with more advanced bladder cancer?” Cancer Causes and Control, vol. 4, no. 2, pp. 157–162, 1993. View at Google Scholar · View at Scopus
  15. S. R. Sturgeon, P. Hartge, D. T. Silverman et al., “Associations between bladder cancer risk factors and tumor stage and grade at diagnosis,” Epidemiology, vol. 5, no. 2, pp. 218–225, 1994. View at Google Scholar · View at Scopus
  16. Z. F. Zhang, X. M. Shu, C. Cordon-Cardo et al., “Cigarette smoking and chromosome 9 alterations in bladder cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 6, no. 5, pp. 321–326, 1997. View at Google Scholar · View at Scopus
  17. H. Wallerand, A. A. Bakkar, S. G. D. de Medina et al., “Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens,” Carcinogenesis, vol. 26, no. 1, pp. 177–184, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Cordon-Cardo, “Molecular alterations associated with bladder cancer initiation and progression,” Scandinavian Journal of Urology and Nephrology, vol. 42, supplement 218, pp. 154–165, 2008. View at Publisher · View at Google Scholar
  19. X. R. Wu, “Urothelial tumorigenesis: a tale of divergent pathways,” Nature Reviews Cancer, vol. 5, no. 9, pp. 713–725, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. J. J. Munoz and L. M. Ellison, “Upper tract urothelial neoplasms: incidence and survival during the last 2 decades,” Journal of Urology, vol. 164, no. 5, pp. 1523–1525, 2000. View at Google Scholar · View at Scopus
  21. R. Montironi, R. Mazzucchelli, M. Scarpelli, A. Lopez-Beltran, and L. Cheng, “Morphological diagnosis of urothelial neoplasms,” Journal of Clinical Pathology, vol. 61, no. 1, pp. 3–10, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Holmäng, H. Hedelin, C. Anderström, E. Holmberg, and S. L. Johansson, “Prospective registration of all patients in a geographical region with newly diagnosed bladder carcinomas during a two-year period,” Scandinavian Journal of Urology and Nephrology, vol. 34, no. 2, pp. 95–101, 2000. View at Publisher · View at Google Scholar